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Background: Accurate assessment of mitral regurgitation (MR) severity is crucial for clinical decision-making and optimizing 
patient outcomes. Recent advances in real-time three dimensional (3D) echocardiography provide the option of real-time full 
volume color Doppler echocardiography (FVCD) measurements. This makes it practical to quantify MR by subtracting aortic 
stroke volume from the volume of mitral inflow in an automated manner.
Methods: Thirty-two patients with more than a moderate degree of MR assessed by transthoracic echocardiography (TTE) 
were consecutively enrolled during this study. MR volume was measured by 1) two dimensional (2D) Doppler TTE, using the 
proximal isovelocity surface area (PISA) and the volumetric quantification methods (VM). Then, 2) real time 3D-FVCD was 
subsequently obtained, and dedicated software was used to quantify the MR volume. MR volume was also measured using 3) 
phase contrast cardiac magnetic resonance imaging (PC-CMR). In each patient, all these measurements were obtained within the 
same day. Automated MR quantification was feasible in 30 of 32 patients.
Results: The mean regurgitant volume quantified by 2D-PISA, 2D-VM, 3D-FVCD, and PC-CMR was 72.1 ± 27.7, 79.9 ± 
36.9, 69.9 ± 31.5, and 64.2 ± 30.7 mL, respectively (p = 0.304). There was an excellent correlation between the MR volume 
measured by PC-CMR and 3D-FVCD (r = 0.85, 95% CI 0.70-0.93, p < 0.001). Compared with PC-CMR, Bland-Altman 
analysis for 3D-FVCD showed a good agreement (2 standard deviations: 34.3 mL) than did 2D-PISA or 2D-VM (60.0 and 62.8 
mL, respectively).
Conclusion: Automated quantification of MR with 3D-FVCD is feasible and accurate. It is a promising tool for the real-time 
3D echocardiographic assessment of patients with MR.
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Introduction
Mitral regurgitation (MR) is one of the most prevalent val-
vular heart diseases. It is estimated that at least 2 million indi-
viduals in the USA are thought to have a moderate or severe 
degree of MR.1) Quantifying the severity of MR is important 
because it is related to the prognosis and guidance for the 
management of patients.2-5) Currently, the standard method to 
quantify MR is two-dimensional (2D) transthoracic echocar-
diography (TTE) using either the color Doppler by volumet-
ric quantification method (VM) or the proximal isovelocity 
surface area (PISA) method.2)6) However, methods that utilize 
2D TTE are limited by multiple assumptions which can in-
troduce error in the quantification of MR severity.7)8) Because 
of this and the inherent complexity of regurgitation, current 
quantification methods with color Doppler require a multi-
ple-step process, are user-dependent, and cannot be applied to 
multiple eccentric MR.
It is now possible to obtain three-dimensional (3D), full 
volume, continuous beat-to-beat color Doppler in real time. 
Additionally, commercially available algorithms are developed 
that can detect the endocardial border of the left ventricle (LV) 
in an automated manner. By utilizing and extending these al-
gorithms, more accurate measurements of flow rate and volume 
are possible. Also, there is potential to minimize the geometric 
assumptions involved in these measurements in a practical 
manner.9-11) Thavendiranathan et al.12) automatically quanti-
fied mitral inflow and LV outflow (LVOT) stroke volumes (SV) 
by real time 3D full volume color Doppler echocardiography 
(FVCD) and compared these results with those from 2D pulsed-
wave (PW) Doppler and cardiac magnetic resonance imaging 
(CMR). They showed that real time 3D-FVCD imaging with 
an automated quantification algorithm is feasible, accurate, 
and reproducible for measuring mitral inflow and LVOT SV 
and is superior to manual 2D TTE-based measurements.
In this study, we aimed to explore the feasibility and accuracy 
of automated quantification of MR by real time 3D-FVCD, 
comparing it with conventional 2D Doppler TTE and phase 
contrast CMR (PC-CMR).
Methods
Study population and protocols
Over the duration of study, 32 consecutive patients with 
more than a moderate degree of MR were prospectively en-
rolled. Severity of MR was defined by effective orifice area 
and/or amount of MR volume obtained by the 2D TTE PISA 
method, as described in the 2003 American Society of Echo-
cardiography (ASE) recommendation.2) Patients with signifi-
cant aortic regurgitation, abnormal intracardiac shunt, signifi-
cant arrhythmia including ventricular arrhythmia and poorly 
controlled atrial fibrillation (heart rate > 100 beat per minute 
and/or beat to beat variability > 30 beat per minute), and con-
traindication to CMR were excluded. Organic MR was de-
fined as MR related with intrinsic valvular abnormalities. 
Functional MR was defined as leaflet tethering or incomplete 
coaptation of leaflets in the presence of normal mitral valve 
anatomy and regional or global LV remodeling.13)
The MR volume in all participants was quantified by 2D 
TTE (both the VM and PISA method), 3D-FVCD, and PC-
CMR. These measurements were all obtained within the same 
day in each patient. Informed consent was obtained from all 
study participants, and the study protocol was approved by 
the Ethics Committee of Severance Hospital.
Two-dimensional echocardiography acquisition
Two-dimensional TTE was performed according to the 
standards of the ASE on an ACUSON SC2000TM ultrasound 
system (Siemens Medical Solutions USA Inc., Mountain View, 
CA, USA) with a 4V1c phased-array transducer at a frequency 
of 4.5 MHz.14) MR volume (mL) was quantified by using the 
PISA method according to ASE guidelines.2) PISA was mea-
sured in the apical view, where the hemispheric morphology 
of flow convergence can be optimized and continuous Doppler 
signal can be well-aligned with the regurgitant jet. Doppler 
aliasing velocity was shifted to optimize the appearance of PISA 
(from 31.0 to 42.0 cm/sec, mean 36.2 ± 7.1 cm/sec). The VM 
method was also used to quantify the MR volume. The diam-
eter of the mitral annulus (MA) was measured in the apical 
four chamber view at the base of the leaflets. LVOT diameter 
was measured in the parasternal long axis view just below the 
aortic annulus at the time of maximal valvular opening. The 
PW Doppler signal of MA inflow and LVOT outflow was 
achieved at the same anatomic location at which the MA and 
LVOT measurements were obtained in the apical four cham-
ber view and the apical long axis view (APLAX), respectively. 
MR volume was calculated by subtracting LVOT SV from 
MA SV.15)16)
In case of atrial fibrillation, MR volume was quantified by 
both the PISA and VM methods when the preceding and pre-
preceding R-R intervals differed less than 10%.
Real time 3D-FVCD acquisition
Using the ACUSON SC2000TM ultrasound system with a 
4Z1c real-time volume imaging transducer (2.8 MHz), three 
consecutive beats of real time FVCD images with a clear elec-
trocardiographic signal were acquired. In case of atrial fibrilla-
tion, image acquisition was performed when the R-R interval 
was regular, in which preceding and pre-preceding R-R inter-
vals differed by less than 10%. The imaging plane was adjust-
ed to clearly visualize the LVOT and MA in a single volume 
within the APLAX. System settings including depth and col-
or Doppler region of interest (ROI) were optimized to maxi-
mize the color volume rates (lower depth and narrowing the 
focus on LV, mitral valve (MV) and aortic valve (AV) will in-
crease color volume rates, typically > 15-25 volume per sec-
ond), while ensuring that complete MV inflow and LVOT 
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were captured without exclusion of any mitral or aortic annu-
lar color flow. Color Doppler frequency was adjusted at 2.0 
MHz, and the color Doppler velocity scale was adjusted to 
minimize aliasing, unless significant aliasing was not detected 
in 2D TTE acquisition. During acquisition, two 2D reference 
planes focused on mitral and aortic valve were displayed at the 
left side of the screen to ensure the ROI is contained within 
the volume (Fig. 1A and B). Analysis of the acquired Digital 
Imaging and Communications in Medicine data was conduct-
ed offline using prototype software (Siemens Medical Solu-
tions USA Inc., Mountain View, CA, USA) that has been pre-
viously validated.12)17)
Automated quantification of mitral 
regurgitant volume
The following steps were performed in an automated man-
ner for quantifying mitral regurgitant volume (RV) using pro-
totype software: 1) automated anatomy detection of the LV 
endocardial border, MA, and the LVOT was performed utiliz-
ing knowledge-based anatomy recognition algorithms.18) 2) 
The algorithm tracked the 3D motion of the detected LV 
wall, MA, and the LVOT as estimated by fusing information 
from multiple cues, including optical flow, boundary detec-
tion, and motion prior. Optical flow is a method of image in-
tensity displacement tracking between two frames, boundary 
detection identifies the learned 3D image features associated 
with the LV border, and motion prior is a learned statistical 
motion model of the LV border.12)17) 3) The software placed 
3D hemispheric flow sampling planes in MA and LVOT. The 
locations of these planes were dynamically adjusted through-
out the cardiac cycles. Three parallel sampling planes spaced 1 
to 2 mm apart were placed at each location, and an average of 
the flow rates at these three planes was computed to minimize 
the impact of the variation in SV due to location.19) For a typi-
cal system setting of 14-17 cm in depth, a color ROI size cov-
ering both the aortic and mitral valves, and volume rates of 
14-34 volumes/sec, the estimated color Doppler voxel dimen-
sion at the sampling plane was 4.5 × 5.0 × 0.6 mm in the azi-
Fig. 1. Quantitative analysis of mitral regurgitation by 3D-FVCD. 3D image acqusition of LVOT (A) and mitral inflow (B) in same 
apical long axis plane. Automated anatomy detection of the LV endocardial border, mitral annulus, LVOT, and placement of three 
dimensional hemispheric flow sampling planes in the MA and LVOT (C). Flow-time curve derived from automatic flow volume 
aggregation at each frame in the cardiac cycle, and the automated calculation of the mitral and aortic SVs of both the MA and LVOT 
flow in 3 cardiac cycles (D). 3D: three dimension, FVCD: full volume color Doppler echocardiography, LVOT: left ventricular outflow 
tract, LV: left ventricle, MA: mitral annulus, SV: stroke volume.
C
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muthal, elevational, and range directions. The final rendered 
voxel dimension of about 0.4 mm isotropic was obtained af-
ter interpolation and scan conversion per conventional ultra-
sound imaging methods (Fig. 1C). 4) The software detected 
the flow velocities at each voxel in the sampling plane and 
computed the flow volume by aggregating all the sample 
color flow values. A flow-time curve was derived from flow 
volume aggregated at each frame in the cardiac cycle, and a 
calculation of the mitral and aortic SVs was performed by 
temporal integration of this curve (Fig. 1D). 5) Based on the 
tracked LV endocardial boundaries, a de-aliasing factor was 
calculated as the ratio of the instantaneous LV volume change 
between two neighboring frames to the flow volume change 
at the MA (during diastole) or the LVOT (during systole) 
during the same two frames. This de-aliasing factor was then 
automatically applied to each frame if aliased flow was de-
tected by the algorithm. 6) The de-aliased flows of three con-
secutive cardiac cycles were displayed as a flow-time curve 
and additional, optional operator-defined de-aliasing adjust-
ments may have been performed if automated de-aliasing was 
incomplete, expressed as a notch in the flow-time curve (Fig. 
2). 7) The software computed the flow volumes as areas under 
the curves of both the MA and LVOT flow in three cardiac 
cycles, and MR volume was calculated by subtracting LVOT 
SV from MA SV.
PC-CMR data acquisition and analysis
CMR was performed utilizing a 1.5-T magnet using a 
12-channel phased-array coil (Philips, Andover, MA, USA). 
LV total SV was calculated in short axis cine images covering 
the LV by subtracting LV end systolic volume from LV end 
diastolic volume using manual contouring of the endocardial 
borders and Simpson’s method. Typical repetition time was 
3.1 ms, and echo time was 1.5 ms with slice thicknesses of 10 
mm for 25 phases. Aortic SV was obtained by through-plane 
phase-contrast imaging with the imaging plane prescribed 
2-3 cm above the aortic valve in an orthogonal orientation to 
the aortic root (typical repetition time: 4.7 ms, echo time: 2.8 
ms, slice thickness: 8 mm; 50 frames/cardiac cycle; aliasing 
velocity: 200 cm/sec; number of excitations: 2). MR volume 
was calculated by subtracting aortic SV from LV total SV.
Reproducibility analysis
To determine intra-observer and inter-observer reproduc-
ibility, 2D- and 3D-FVCD image analysis was repeated by a 
second observer in 10 randomly selected patients at a different 
time point and as well as by the primary reader at least one 
month later. During all analyses, examiners were all blinded 
to the results of previous measurements.
Statistical analysis
Continuous variables are presented as the mean ± standard 
deviation. Mean mitral RV quantified by 2D-PISA, 2D-VM, 
3D-FVCD, and PC-CMR were compared by one-way analysis 
of variance (ANOVA) and by the non-parametric Kruskal-
Wallis test. Categorical variables are presented as absolute 
numbers or percentages. Linear regression analysis (Pearson 
correlation) was performed to evaluate the correlation between 
variables. Bland-Altman plots were used to evaluate differenc-
es in RV assessments between 2D TTE, 3D-FVCD, and PC-
CMR. Mean differences and limits of agreement are reported. 
Intraclass correlation coefficient (ICC) was used to measure 
and compare agreement of RV between PC-CMR and other 
methods. To evaluate intra-observer and inter-observer repro-
ducibility, ICC was calculated. Good correlation was defined 
as an ICC > 0.8. All analyses were performed using PAWS 
statistic version 18.0 (SPSS Inc., Chicago, IL, USA) and Med-
Calc version 12.3 (MedCalc Software, Mariakerke, Belgium). 
A p value < 0.05 was considered statistically significant.
Results
A total of 32 patients with more than a moderate degree of 
MR were initially assessed for inclusion. Two patients were 
excluded due to inadequate 2D and 3D color Doppler images. 
The MR volume of the remaining 30 could be assessed with 
3D-FVCD and prototype software in an automated manner. 
The mean volume rate of 3D-FVCD images was 20.2 ± 4.6 
Fig. 2. Flow de-aliasing: flow aliasing in the LVOT (A, white arrow) and 
MA planes (B, white arrowhead) are well visualized. Even after 
automated de-aliasing, there are still visible notches in LVOT flow (C, 
white arrows) and MA flow (C, white arrowheads) indicating incomplete 
de-aliasing on flow-time curve. Additional operator defined de-aliasing 
adjustment is performed, resulting in completely de-aliased flow (D). 
LVOT: left ventricular outflow tract, MA: mitral annulus.
A
C
D
B
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volumes/second and ranged from 15-29 volumes/second.
The study population consisted of 15 men and 15 women 
(mean age 56 ± 13 years). Population characteristics are shown 
in Table 1. Eighteen patients were in sinus rhythm, and 12 
patients showed atrial fibrillation on the electrocardiogram. 
All the patients with atrial fibrillation showed low variability 
in heart rate (beat-to-beat variability < 30 bpm). Mean LV 
end-diastolic dimension and end-systolic dimension as mea-
sured with 2D-TTE were 61.0 ± 9.3 mm and 42.8 ± 11.7 
mm, respectively. Mean left atrial volume index was 80.3 ± 
54.2 mL, and mean LV ejection fraction was 58.8 ± 18.3%.
Severity and characteristics of MR are shown in Table 1. Based 
on the RV measurements by 2D-PISA, 14 (46.7%) patients had 
grade 3, and 16 (53.3%) patients had grade 4 MR. Functional 
MR was present in eight (26.7%) patients and organic MR in 
22 (73.3%) patients. Central or eccentric mitral regurgitant jets 
were observed in nine (30.0%) and 21 (70.0%) patients, respec-
tively. There were multiple regurgitant jets in ten (33.3%) pa-
tients and single jet in 20 (66.7%) patients, respectively.
Comparison of 2D-TTE and RT-FVCD
The mean RV quantified by 2D-PISA, 2D-VM, 3D-FVCD, 
and PC-CMR was 72.1 ± 27.7, 79.9 ± 36.9, 69.9 ± 31.5, 
and 64.2 ± 30.7 mL, respectively. No significant differences 
between groups was observed (p = 0.304 by one way ANO-
VA, and p = 0.160 by Kruskal-Wallis test). The correlation 
between RV-3D-FVCD and RV-PC-CMR; RV-2D-PISA and 
Fig. 3. Correlation and agreement between tests. Linear regression plots showing correlation between RV-3D-FVCD and PC-CMR (A); RV-2D-VM 
and PC-CMR (B); RV-2D-PISA and PC-CMR (C). Bland-Altman analysis for 3D-FVCD (D) shows better limits of agreement and smaller bias than 
2D-VM (E) and 2D-PISA (F). RV: regurgitant volume, 3D: three dimension, FVCD: full volume color Doppler echocardiography, PC: phase contrast, 
CMR: cardiac magnetic resonance imaging, 2D: two dimension, VM: volumetric method, PISA: proximal isovelocity surface area, MR: mitral 
regurgitation, SD: standard deviation.
Table 1. Baseline characteristics of patients and mitral regurgitation 
by two-dimensional echocardiography
Variables Values
Age (yr)   56 ± 13
Male gender 15 (50.0)
Atrial fibrillation 12 (40.0)
LVEF (%)   58.8 ± 18.3
LVEDD 61.0 ± 9.3
LVESD   42.8 ± 11.7
LA volume index   80.3 ± 54.2
Degree of MR
    Grade III 14 (46.7)
    Grade IV 16 (53.3)
Etiology of MR
    Functional MR   8 (26.7)
    Organic MR 22 (73.3)
Eccentricity of MR
    Central   9 (30.0)
    Eccentric 21 (70.0)
Number of MR
    Single 20 (66.7)
    Multiple 10 (33.3)
Data are presented as the number (%) or mean ± standard deviation. 
LVEF: left ventricular ejection fraction, LVEDD: left ventricular end 
diastolic dimension, LVESD: left ventricular end systolic dimension, LA: 
left atrium, MR: mitral regurgitation
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RV-PC-CMR; and RV-2D-VM and RV-PC-CMR are shown 
in Fig. 3A, B and C. There was a more excellent correlation 
between RV-PC-CMR and RV-3D-FVCD (r = 0.85, 95% CI 
0.70-0.93, p < 0.001) than RV-PC-CMR and RV-2D meth-
ods (PISA r = 0.55, 95% CI 0.23-0.76, p = 0.002; VM r = 
0.58, 95% CI 0.27-0.78, p = 0.001). The agreement between 
2D-TTE and both 3D-FVCD and PC-CMR as evaluated by 
Bland-Altman analysis is illustrated in Fig. 3D, E and F. 
Compared with PC-CMR, Bland-Altman analysis for 3D-
FVCD showed better limits of agreement and smaller bias [2 
standard deviation (2SD): 34.3 mL; bias: -5.7 mL] than 2D-
PISA and 2D-VM (2SD: 60.0 mL; bias: -7.9 mL, and 2SD: 
62.8 mL; bias: -16.7 mL), respectively. The agreement be-
tween RV-PC-CMR and RV-3D-FVCD evaluated by ICC 
(0.85, 95% CI 0.71-0.93) was better than RV-PC-CMR and 
RV-2D TTE methods (0.54, 95% CI 0.23-0.75 within PC-
CMR and 2D-PISA; and 0.57, 95% CI 0.27-0.77 within PC-
CMR and 2D-VM).
A representative case of MR volume comparison between 
respective modalities is demonstrated in Fig. 4.
Intra- and inter-observer analysis
Excellent and comparable intra-observer and inter-observer 
agreement for 3D-FVCD measures was observed, with an ICC 
Fig. 4. A representative case comparing the quantitative analysis of MR by different tests. MR volume by 2D-PISA (A) is 
underestimated compared with MR volume estimated by PC-CMR (D) due to the eccentric nature of MR with irregular, horizontally 
ellipsoid PISA morphology (white arrow). MR volume quantified by 2D-VM (B) is overestimated because of oversizing of the MA. MR 
volume by 3D-FVCD (C) shows excellent agreement with PC-CMR (D), despite the presence of flow aliasing (white arrowhead). MR: 
mitral regurgitation, 2D: two dimension, PISA: proximal isovelocity surface area, PC: phase contrast, CMR: cardiac magnetic 
resonance imaging, VM: volumetric method, 3D: three dimension, FVCD: full volume color Doppler echocardiography.
C
A
D
BRV 81.0 mL
RV 101.8 mL
RV 127.3 mL
RV 103.9 mL
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of 0.97 and 0.89, respectively, compared with 2D-PISA (0.94 
and 0.88) and 2D-VM (0.93 and 0.87).
Discussion
This study demonstrates the quantification of the MR vol-
ume using real time transthoracic 3D-FVCD and validates 
the accuracy by comparing it with CMR. It was feasible, re-
producible, and accurate to quantify MR by 3D-FVCD with 
an automated quantification of MR volume.
Present standard methods for MR quantification are the 
PISA and volumetric methods using 2D TTE.2)6) Although 
2D methods are well-validated and guidelines recommend us-
ing these methods for MR quantification, these methods have 
many innate limitations and assumptions.20)21) The PISA meth-
od assumes the hemispheric shape of the PISA. However, the 
shape of the PISA can vary depending on the shape of the re-
gurgitant orifice and instrument settings, which may lead to a 
miscalculation of effective regurgitant orifice area and the MR 
volume.8) Direct measurement of the PISA using real time 3D 
color Doppler echocardiography can overcome this limita-
tion.22) However, the inability of the PISA method to quantify 
eccentric and multiple MR cannot be overcome. Using the 
volumetric method (which measures mitral inflow and aortic 
SVs) to calculate the MR volume is an alternative as it is free 
from the assumptions and limitations of the PISA method. 
However, this 2D TTE flow quantification method also has 
limitations. The relative ovoid shape of the MA, which is as-
sumed as circular, can introduce error when calculating MA 
cross-sectional area, and geometric variation in the cross-sec-
tional valvular areas over the cardiac cycle is not accounted for. 
Small measurement errors of the LVOT or MA diameter may 
lead to large differences in SVs. In addition, since PW Dop-
pler of LVOT flow and MA flow are obtained in a separate 
echocardiographic windows, the timing of the measurements 
are different and can introduce error.
CMR is often used as a reference method for MR quantifica-
tion because it is 1) the most accurate non-invasive technique 
for quantifying the LV SV,23) and 2) the phase contrast velocity 
flow mapping of the aortic forward SV is also accurate and re-
producible, which can be a more objective and consistent meth-
od for quantifying eccentric and multiple MR.
3D-FVCD uses a similar mechanism as PC-CMR for quan-
tifying AV and MV stoke volume, and it quantifies the MR 
by subtracting AV SV from MV SV. By using this technique 
we can quantify the eccentric and multi-jet MRs more accu-
rately than by 2D-PISA. Furthermore, unlike 2D VM, the 
3D-FVCD method does not assume the geometric morpholo-
gy of the MA and LVOT, but automatically detects the plane 
of the MA and LVOT and calculates the flow crossing this 
plane, which overcomes the limitation of 2D VM. Because of 
these merits, we found that the accuracy, agreement, and inter- 
and intra-observer variability of MR quantification by 3D-
FVCD was better than the 2D methods, even though the pro-
portion of eccentric and multi-jet MR is high in our study. 
Moreover, feasibility is comparable with 2D TTE. Further-
more, the workflow of image acquisition, measurement, and 
analyzing of the MR volume by 3D-FVCD is a relatively sim-
ple and automated process, which can be easily applicable in 
clinical practice.
The most difficult problem to overcome in the 3D-FVCD 
method is “aliasing”. Aliasing remains a limitation of ultra-
sound physics. In the previous study of quantifying the mitral 
inflow and aortic outflow SVs automatically by real time 3D-
FVCD in normal population, the flow velocity across both the 
MA and LVOT planes usually did not exceed the limit of Ny-
quist.12) Therefore, aliasing of flow was not a major issue. Even 
in cases where there was aliasing of flow, automated de-alias-
ing was able to be performed properly. However, a certain pro-
portion of subjects (32%) needed to be reassessed by using addi-
tional operator-defined, automated de-aliasing mechanisms.12) 
In our study, we maximized the color Doppler scale to avoid 
aliasing whenever possible. The aliasing of the flow in both 
annulus planes was common given the increased blood vol-
ume flow through these planes resulting from MR. As a re-
sult, additional operator-defined automated de-aliasing had to 
be performed in 26 patients (86.7%). After this de-aliasing, 
the MR volume quantified by 3D-FVCD showed an excellent 
correlation and agreement with reference method, CMR.
Clinical implication
By using the 3D-FVCD method, we expect to quantify the 
MR volume more accurately, especially in the subgroup of pa-
tients with eccentric and multi-jet MR. Also, we can extend 
the application of 3D-FVCD to quantifying right side heart 
flow, such as right ventricular SV, which can be used to calcu-
late the amount of left to right shunt (Qp/Qs) and pulmonary 
vascular resistance in a patient with an intracardiac shunt or 
pulmonary hypertension. Other valvular regurgitations, such 
as tricuspid regurgitation, aortic regurgitation, and pulmonic 
regurgitation, can be quantified by a similar workflow.
Limitation
There were several limitations within our study. First, a rel-
atively small number of patients were included. Second, al-
though all the patients were enrolled consecutively, this study 
is a single-center prospective observational study and subject 
to intrinsic limitation. Third, PC-CMR, the reference method 
for MR volume quantification, also has several innate limita-
tions. The PC-CMR method for directly quantifying MV in-
flow volume is technically difficult due to vigorous movement 
of MV plane. So, instead of using the phase-contrast method 
for directly quantifying the MV inflow volume, we obtained 
LV SV by manual contouring of the endocardial borders and 
Simpson’s method. Also, aortic SV is obtained at a plane above 
the aortic valve, which was different from the LVOT plane used 
in the 3D-FVCD method. Due to these limitations, a direct 
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comparison of MV and LVOT SV between 3D-FVCD and 
CMR could not be achieved. However, the CMR method is 
well-validated for quantifying the MR volume and widely 
used in clinical practice and research studies.23)24) Fourth, there 
was a relatively large number of patients with atrial fibrilla-
tion included in this study. Atrial fibrillation is more common 
in patients with MR, and this can reduce the accuracy of flow 
measurements not only by echocardiography but also by CMR. 
However, we only included those patients with atrial fibrilla-
tion who also had low heart rate variability (beat to beat vari-
ability < 30 beat per minute). In these patients, the MR vol-
ume quantified by CMR using the indirect method was not 
significantly different from the MR volume quantified by the 
direct method, which is independent from irregular rhythm.25) 
In addition, we acquired and quantified the MR volume by 
both 2D and 3D methods in the cardiac cycles of preceding 
and pre-preceding R-R intervals differing less than 10% to 
minimize any beat-to-beat variation.
Conclusion
In summary, the data from this study show that automated 
quantification of MR with 3D-FVCD is feasible and accurate. 
3D-FVCD is a novel and promising tool of real-time 3D echo-
cardiography in the evaluation of patients with MR.
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